Berkely Lights
Company Details
Status: Public
Employees: 101-250
Location:
Emeryville, California, United States
Type:
sample
Technology:
sample
About: 3/21/23- Acquired IsoPlexis Corporation (Nasdaq: ISO) then renamed to create PhenomeX. On Aug. 17, 2023, PhenomeX and Bruker entered into a merger agreement.
Berkeley Lights is a leading functional cell biology company focused on enabling and accelerating the rapid development and commercialization of bio-therapeutics and other cell-based products for our customers. The Berkeley Lights Platform captures deep phenotypic, functional and genotypic information for thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. Our platform is a fully integrated, end-to-end solution, comprising proprietary consumables, including our OptoSelect™ chips and reagent kits, advanced automation systems, and application software. We developed the Berkeley Lights Platform to provide the most advanced environment for rapid functional characterization of single cells at scale, the goal of which is to establish an industry standard for our customers throughout their cell-based product value chain.
Berkeley Lights’ Beacon® and Lightning™ systems and Culture Station™ instrument are for research use only. Not for use in diagnostic procedures.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Berkely Lights | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.